Large Employers, Insurers, PCMA Ask CMS To Retain Formulary Tools
This article was originally published in The Pink Sheet Daily
Executive Summary
A group of large employers, insurance companies and the Pharmaceutical Care Management Association has sent a letter to the Centers for Medicare & Medicaid Services arguing that the Medicare drug benefit should permit a wide range of cost effectiveness tools